PerkinElmer
check quantity

CellCarrier-1536, Black, Optically Clear Bottom, Tissue Culture Treated, Sterile, 1536-Well with Lid, Case of 80

1536-well TC-treated black microplate with optically clear bottom for high content analysis (HCA), high content screening (HCS), and other cellular assays.

Part Number
Unit Size
List Price
Your Price
Quantity
6004550
Case of 20
971.00 USD
 
more
6004558
Case of 80
3882.00 USD
 
more
Buy Now

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

Overview

PerkinElmer's exclusive CellCarrier™ microplates have a unique patented design for high content imaging readers and are ideal for use with the Opera® High Content Screening System. These CellCarrier 1536-well microplates are black with an optically clear bottom. They are tissue culture treated, sterile, and each plate has a lid. The case contains 20 microplates.

Specifications

Automation Compatible Yes
Coating Treatment TC-treated, Sterile
Color Black/Clear Bottom
Detection Method Confocal Imaging, Fluorescence, High Content Imaging
Material Polystyrene
Product Brand Name CellCarrier
Shipping Condition Ambient
Sterile Yes
Unit Size Case of 80
Wells Number 1536 well plate
Resources, Events & More
  • All

Brochure

Drug Discovery Screening Solutions Brochure

Find out about our range of integrated solutions for drug discovery screening in this e-brochure.

Our screening solutions for high-throughput screening, phenotypic screening and data analysis help to streamline drug discovery workflows in labs across the globe. Our portfolio includes automated liquid handling, assays and reagents, imaging and detection systems, and informatics.

Working independently or together, with our solutions you can achieve consistent and accurate results. By accelerating the identification and characterization of effective and safe drug candidates, the PerkinElmer portfolio enables you to optimize efficiency in your lab and deliver more actionable, real-world results.

Download the brochure to learn more about how we can partner with you so that you can discover smarter, more effective, data-driven breakthroughs in the critical screening stages of drug discovery and development.

PDF 4 MB